|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 7
2022
Glajzer, Jacek; Castillo-Tong, Dan Cacsire; Richter, Rolf; Vergote, Ignace; Kulbe, Hagen; Vanderstichele, Adriaan; Ruscito, Ilary; Trillsch, Fabian; Mustea, Alexander; Kreuzinger, Caroline; Gourley, Charlie; Gabra, Hani; Taube, Eliane T.; Dorigo, Oliver; Horst, David; Keunecke, Carlotta; Baum, Joanna; Angelotti, Timothy; Sehouli, Jalid und Braicu, Elena Ioana
(2022):
Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
In: Annals of Surgical Oncology, Bd. 30, Nr. 1: S. 35-45
Braicu, Elena Ioana; du Bois, Andreas; Sehouli, Jalid; Beck, Julia; Prader, Sonia; Kulbe, Hagen; Eiben, Bernd; Harter, Philipp; Traut, Alexander; Pietzner, Klaus; Glaubitz, Ralf; Ataseven, Beyhan; Chekerov, Radoslav; Keck, Christoph; Winkler, Thomas; Heikaus, Sebastian; Gellendin, Peggy; Schuetz, Ekkehard und Heitz, Florian
(2022):
Cell-Free-DNA-Based Copy Number Index Score in Epithelial Ovarian Cancer-Impact for Diagnosis and Treatment Monitoring.
In: Cancers, Bd. 14, Nr. 1, 168
2021
Salminen, Liina; Braicu, Elena Ioana; Laaperi, Mitja; Jylha, Antti; Oksa, Sinikka; Hietanen, Sakari; Sehouli, Jalid; Kulbe, Hagen; du Bois, Andreas; Mahner, Sven; Harter, Philipp; Carpen, Olli; Huhtinen, Kaisa; Hynninen, Johanna und Hilvo, Mika
(2021):
A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer.
In: Cancers, Bd. 13, Nr. 8, 1764
2019
Guan, Jun; Darb-Esfahani, Silvia; Richter, Rolf; Taube, Eliane T.; Ruscito, Ilary; Mahner, Sven; Woelber, Linn; Prieske, Katharina; Concin, Nicole; Vergote, Ignace; Van Nieuwenhuysen, Els; Achimas-Cadariu, Patriciu; Glajzer, Joanna; Woopen, Hannah; Stanske, Mandy; Kulbe, Hagen; Denkert, Carsten; Sehouli, Jalid und Braicu, Elena Ioana
(2019):
Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium.
In: Journal of Cancer Research and Clinical Oncology, Bd. 145, Nr. 4: S. 1063-1073
2018
Ruscito, Ilary; Castillo-Tong, Dan Cacsire; Vergote, Ignace; Ignat, Iulia; Stanske, Mandy; Vanderstichele, Adriaan; Glajzer, Jacek; Kulbe, Hagen; Trillsch, Fabian; Mustea, Alexander; Kreuzinger, Caroline; Panici, Pierluigi Benedetti; Gourley, Charlie; Gabra, Hani; Nuti, Marianna; Taube, Eliane T.; Kessler, Mirjana; Sehouli, Jalid; Darb-Esfahani, Silvia und Braicu, Elena Ioana
(2018):
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
In: British Journal of Cancer, Bd. 119, Nr. 3: S. 330-338
Darb-Esfahani, Silvia; Kolaschinski, Ivonne; Trillsch, Fabian; Mahner, Sven; Concin, Nicole; Vergote, Ignace; Nieuwenhuysen, Els van; Achimas-Cadariu, Patriciu; Glajzer, Joanna; Woopen, Hannah; Wienert, Stefan; Taube, Eliane T.; Stanske, Mandy; Kulbe, Hagen; Denkert, Carsten; Sehouli, Jalid und Braicu, Elena Ioana
(2018):
Morphology and tumour‐infiltrating lymphocytes in high‐stage, high‐grade serous ovarian carcinoma correlated with long‐term survival.
In: Histopathology, Bd. 73, Nr. 6: S. 1002-1012
2017
Ruscito, Ilary; Castillo-Tong, Dan Cacsire; Vergote, Ignace; Ignat, Iulia; Stanske, Mandy; Vanderstichele, Adriaan; Ganapathi, Ram N.; Glajzer, Jacek; Kulbe, Hagen; Trillsch, Fabian; Mustea, Alexander; Kreuzinger, Caroline; Panici, Pierluigi Benedetti; Gourley, Charlie; Gabra, Hani; Kessler, Mirjana; Sehouli, Jalid; Darb-Esfahani, Silvia und Braicu, Elena Ioana
(2017):
Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
In: European Journal of Cancer, Bd. 79: S. 214-225